Fortress Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fortress Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Fortress Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$12.9M, a 155% decline year-over-year.
  • Fortress Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$48.5M, a 38% increase year-over-year.
  • Fortress Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$60.6M, a 30% increase from 2022.
  • Fortress Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$86.6M, a 33.8% decline from 2021.
  • Fortress Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$64.7M, a 39.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$48.5M -$12.9M -$7.82M -155% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$40.7M -$10.9M +$13.8M +55.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$54.5M -$15.4M +$6.12M +28.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$60.6M -$9.28M +$17.7M +65.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$78.3M -$5.05M +$17.5M +77.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$95.8M -$24.8M -$3.42M -16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$92.4M -$21.5M -$5.78M -36.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$86.6M -$26.9M +$4.62M +14.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$91.2M -$22.5M -$1.73M -8.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$89.5M -$21.4M -$17.8M -504% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$71.6M -$15.8M -$6.94M -78.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$64.7M -$31.6M -$26.3M -496% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$38.4M -$20.8M -$5.23M -33.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$33.2M -$3.54M +$9.78M +73.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$43M -$8.82M +$3.55M +28.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$46.5M -$5.3M +$10.2M +65.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$56.7M -$15.5M -$2.79M -21.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$53.9M -$13.3M -$216K -1.65% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$53.7M -$12.4M -$13.8M -989% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$40M -$15.5M +$9.39M +37.7% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 -$49.3M -$12.8M +$3.88M +23.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$53.2M -$13.1M +$8.51M +39.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$61.7M $1.39M +$22.4M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$84.1M -$24.9M -$14.5M -139% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$69.7M -$16.6M +$10.5M +38.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$80.2M -$21.6M -$4.25M -24.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$75.9M -$21M -$9.04M -75.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$66.9M -$10.4M +$7.02M +40.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$73.9M -$27.1M -$14.1M -109% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$59.8M -$17.4M -$4.89M -39.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$54.9M -$12M +$223K +1.83% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$55.1M -$17.4M -$5.4M -44.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$49.7M -$13M +$5.18M +28.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$54.9M -$12.5M -$6.3M -102% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$48.6M -$12.2M -$149K -1.24% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$48.4M -$12M -$8.32M -224% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$40.1M -$18.2M -$13.6M -295% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$26.5M -$6.18M -$1.46M -31.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$25.1M -$12.1M -$4.69M -63.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$20.4M -$3.71M +$6.09M +62.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$26.5M -$4.59M +$3.24M +41.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$29.7M -$4.71M +$5.96M +55.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$35.7M -$7.37M +$1.49M +16.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$37.2M -$9.8M -$1.13M -13.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$36M -$7.83M -$1.9M -32% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$34.1M -$10.7M -$4.22M -65.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$29.9M -$8.86M -$2.3M -35.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$27.6M -$8.66M -$1.95M -28.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$25.7M -$5.94M -$2.57M -76.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$23.1M -$6.46M -$2.72M -72.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$20.4M -$6.56M +$16M +70.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$36.4M -$6.72M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$3.37M -$1.25M -58.7% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$3.73M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$22.5M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$2.12M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.